Clinical Trial Update: Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CMV-specific donor lymphocyte infusions from 3-6/6 HLA-matched family members after nonmyeloablative allogeneic stem cell transplantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• CMV-specific donor lymphocyte infusion (donor lymphocyte infusion (CMV-specific))

Snippet

Sponsor: Nelson Chao | Conditions: Cytomegalovirus Infections | Phase 1 | Status: TERMINATED